Effect of combined with small doses of thalidomide and low -dose dexamethasone VAD scheme in treatment of elderly multiple myeloma
10.3760/cma.j.issn.1008-6706.2016.03.019
- VernacularTitle:小剂量沙利度胺联合含小剂量地塞米松的VAD 方案治疗老年人多发性骨髓瘤的疗效观察
- Author:
Xinhua WU
;
Liwei WANG
;
Chengda YUAN
- Publication Type:Journal Article
- Keywords:
Multiple myeloma;
Thalidomide;
Dexamethasone;
Aged
- From:
Chinese Journal of Primary Medicine and Pharmacy
2016;23(3):391-393,394
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the curative effect of combined with small dose of thalidomide and low -dose dexamethasone VAD regimen for the elderly multiple myeloma (MM).Methods 58 MM cases were randomly divided into control group(28 cases)and treatment group (30 cases).The control group received VAD regimen.The treatment group added with small doses of thalidomide treatment (TVAD scheme).The,hemoglobin (HGB),creati-nine (Cr),bone marrow plasma cell counting,M protein level,Carr's score (KPS)and side effects of chemotherapy were observed in the two groups.Results The effective rates of treatment group and control group were 76.67% and 50.00%,the curative effect of treatment group was better (χ2 =4.459,P <0.05).The HGB,Cr,plasma cells,Mpro-tein and carr's score were improved,but the curative effect of the treatment group was better(P <0.05).Adverse reac-tions such as leucopenia,neuropathy,constipation,gastrointestinal reaction and pulmonary infection were observed in two groups,but there was no significant difference.Conclusion TVAD regimen for MMhas good curative effect and less side effects,it is worthy of promotion.
